[1]
“The 40-gene Expression Profile (40-GEP) Test Identifies Cutaneous Squamous Cell Carcinoma (cSCC) Patients at High Risk of Metastasis within Lower-Staged Tumors to Better Guide Treatment Decisions”, J of Skin, vol. 8, no. 2, p. s385, Mar. 2024, doi: 10.25251/skin.8.supp.385.